Paloma Partners Management CO Gilead Sciences, Inc. Put Options Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.99 Million - $2.25 Million	-27,100 Reduced 63.47%	15,600 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $3.16 Million - $3.44 Million	42,700 New	42,700 $3.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.22 Million - $2.45 Million	-35,500 Reduced 51.9%	32,900 $2.09 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $431,457 - $483,345	6,900 Added 11.22%	68,400 $4.45 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $2.86 Million - $3.49 Million	-39,300 Reduced 38.99%	61,500 $4.64 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $796,880 - $935,424	-11,200 Reduced 10.0%	100,800 $7.22 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $8.08 Million - $9.57 Million	112,000	112,000 $9.07 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.